Empiric antibiotics for peripartum bacteremia: A chart review from a quaternary Canadian centre
International Journal of Gynecology & Obstetrics · 2024-02 · 164 (2) · 786-792
DOI: 10.1002/ijgo.15048 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, 2023-09. Verfasst von Sarah F Mohn und 11 weiteren Autor:innen. Beteiligte Einrichtung: UBC Faculty of Medicine, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Bacteremia, Anti-Infective Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To evaluate the effectiveness of empiric antibiotic protocols for peripartum bacteremia at a quaternary institution by describing incidence, microbial epidemiology, clinical source of infection, susceptibility patterns, and maternal and neonatal outcomes.
Methods
Retrospective chart review of peripartum patients with positive blood cultures between 2010 and 2018.
Results
The incidence of peripartum bacteremia was 0.3%. The most cultured organisms were Escherichia coli (51, 26.7%), Streptococcus spp. (52, 27.2%), and anaerobic spp. (35, 18.3%). Of the E. coli cases, 54.9% (28), 19.6% (10), and 19.6% (10) were resistant to ampicillin, first‐ and third‐generation cephalosporins, respectively. Clinical sources of infection included intra‐amniotic infection/endometritis (115, 67.6%), upper and/or lower urinary tract infection (23, 13.5%), and soft tissue infection (8, 4.7%). Appropriate empiric antibiotics were prescribed in 137 (83.0%) cases. There were 7 ICU admissions (4.2%), 18 pregnancy losses (9.9%), 9 neonatal deaths (5.5%), and 6 cases of neonatal bacteremia (3.7%).
Conclusion
Peripartum bacteremia remains uncommon but associated with maternal morbidity and neonatal morbidity and mortality. Current empiric antimicrobial protocols at our site remain appropriate, but continuous monitoring of antimicrobial resistance patterns is critical given the presence of pathogens resistant to first‐line antibiotics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UBC Faculty of Medicine, Vancouver, British Columbia, Canada.
- BC Women's Hospital and Health Centre, Vancouver, British Columbia, Canada.
- Women's Health Research Institute, Vancouver, British Columbia, Canada.
- BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
- Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada.
- Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.
ORCID-Profile: Sarah F Mohn
Zitieren
APA
Mohn, S. F., Reimer, R., Mar, N., Katelieva, A., Paquette, V., Albert, A. Y. K., Roberts, A., Tilley, P., McClymont, E., Ting, J., Boucoiran, I., & Elwood, C. (2024). Empiric antibiotics for peripartum bacteremia: A chart review from a quaternary Canadian centre. International Journal of Gynecology & Obstetrics, 164(2), 786-792. https://doi.org/10.1002/ijgo.15048
Vancouver
Mohn SF, Reimer R, Mar N, Katelieva A, Paquette V, Albert AYK, et al. Empiric antibiotics for peripartum bacteremia: A chart review from a quaternary Canadian centre. International Journal of Gynecology & Obstetrics. 2024;164(2):786-792. doi:10.1002/ijgo.15048
BibTeX
@article{Mohn2024,
author = {Mohn, Sarah F and Reimer, Renee and Mar, Nicole and Katelieva, Angela and Paquette, Vanessa and Albert, Arianne Y K and Roberts, Ashley and Tilley, Peter and McClymont, Elisabeth and Ting, Joseph and Boucoiran, Isabelle and Elwood, Chelsea},
title = {Empiric antibiotics for peripartum bacteremia: A chart review from a quaternary Canadian centre},
journal = {International Journal of Gynecology & Obstetrics},
year = {2024},
volume = {164},
number = {2},
pages = {786--792},
doi = {10.1002/ijgo.15048}
}
EUVIMED